Benjamin Tan, MD

Medical Oncologist

Primary Academic Title

Associate Professor of Medicine, Division of Oncology, Section of Medical Oncology, Washington University School of Medicine

Clinical Expertise

Gastrointestinal cancer

Research Interest

Phase I developmental therapeutics. In seeking novel treatment strategies for patients with cancer, I hope to find more efficacious and more tolerable regimens. My other major interest is in the area of AIDS-associated malignancies.

Education

1990: MD, University of the Philippines, Manila

Training

1991 - 1994: Resident, internal medicine, Sinai Hospital of Baltimore
1994 - 1997: Clinical fellow, hematology and medical oncology, Washington University, St. Louis
1997 - 1998: Research fellow, hematology and medical oncology, Washington University

Board Certification

1996: American Board of Internal Medicine, Internal Medicine
1997: American Board of Internal Medicine, Medical Oncology

Selected Research Publications

Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702.

Lee S, Ma C, Shi Q, [...] Tan B, [...] Meyerhardt JA
J Clin Oncol 2023

Physical Activity in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance).

Brown JC, Ma C, Shi Q, [...] Tan B, [...] Meyerhardt JA
J Clin Oncol 2023

Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study.

Wang-Gillam A, Lim KH, McWilliams R, [...] Tan B, [...] DeNardo DG
Clin Cancer Res 2022

The Clinical Landscape of Cell-Free DNA Alterations in 1,671 Patients with Advanced Biliary Tract Cancer.

Berchuck JE, Facchinetti F, DiToro DF, [...] Tan B, [...] Goyal L
Ann Oncol 2022

Cost-effectiveness of Total Neoadjuvant Therapy With Short-Course Radiotherapy for Resectable Locally Advanced Rectal Cancer.

Chin RI, Otegbeye EE, Kang KH, [...] Tan BR, [...] Kim H
JAMA Netw Open 2022

Vorolanib (X-82), an oral anti-VEGFR/PDGFR/CSF1R tyrosine kinase inhibitor, with everolimus in solid tumors: results of a phase I study.

Pedersen KS, Grierson PM, Picus J, [...] Tan B
Invest New Drugs 2021

Phase 1 study combining alisertib with nab-paclitaxel in patients with advanced solid malignancies.

Lim KH, Opyrchal M, Acharya A, [...] Tan BR, [...] Wang-Gillam A
Eur J Cancer 2021

Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Esophageal Adenocarcinoma: Results from a Phase 1 Cohort.

Tan B, Khattak A, Felip E, [...] Isambert N
Target Oncol 2021

Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation.

Li L, Zhang X, Wang X, [...] Tan BR, [...] Gillanders WE
Genome Med 2021

Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial.

Meyerhardt JA, Shi Q, Fuchs CS, [...] Tan B, [...] Shields AF
JAMA 2021

Contact Information

South St. Louis County

5225 Midamerica Plaza
St. Louis, MO 63129
Washington University Medical Campus

4921 Parkview Place
Saint Louis, MO 63110

Phone Numbers

Appointments: (314) 747-7222
Toll Free: (800) 600-3606

Request an appointment